Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Beta for Anemia in Low Risk MDS
NCT02428686Phase 2Completed
- Sponsor
- Groupe Français des Myélodysplasies
- Start
- Jun 2010
- Primary completion
- Mar 2014
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta in anemia, sponsored by Groupe Français des Myélodysplasies. Started Jun 2010; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02428686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428686.